Chemical Imaging for Biological Systems: Techniques, AI-Driven Processing, and Applications

Abstract

Visualizing the chemical compositions of biological samples is pivotal to advancing biological sciences, with the past two decades witnessing the emergence of innovative chemical imaging platforms such as single-molecule imaging, coherent Raman scattering microscopy, transient absorption microscopy, photothermal microscopy, ambient ionization mass spectrometry, electrochemical microscopy, and advanced chemical probes. These technologies have enabled significant breakthroughs in diagnosing pathological transitions, designing targeted therapies, and understanding drug resistance mechanisms. Recent advancements in resolution, contrast, sensitivity, and speed have transformed the field, with techniques like fluorescence, infrared absorption, and Raman scattering being widely applied across diverse biological domains. This review provides a comprehensive overview of the evolution and current state of chemical imaging technologies, coupled with systematic analyses of data processing workflows, including pre-processing, machine learning-assisted pattern extraction, and neural network-based predictions. Artificial intelligence (AI) and machine learning-assisted imaging processes are revolutionizing chemical imaging by enabling the efficient analysis of complex datasets, enhancing pattern recognition, and accelerating predictions, thereby significantly benefiting both current applications and the future development of chemical imaging techniques in biomedical research. Looking ahead, the integration of bioimaging into cell biology, lipid research, tumor studies, microbiology, neurobiology, and developmental biology is anticipated to expand its impact, aided by interdisciplinary expertise in biochemistry, physics, and optical engineering. These developments promise unprecedented resolution and speed, facilitating high-speed, high-resolution imaging of living systems, with applications leading to discoveries such as biomarkers for cancer aggressiveness and drug resistance. Moreover, the miniaturization and commercialization of imaging platforms are broadening accessibility, enabling on-site clinical investigations and in vivo measurements, underscoring the transformative potential of chemical imaging in advancing biological science and medical research.